Cathy N Lam
Examiner (ID: 12915)
Most Active Art Unit | 2811 |
Art Unit(s) | 4122, 2811 |
Total Applications | 430 |
Issued Applications | 305 |
Pending Applications | 0 |
Abandoned Applications | 125 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14323931
[patent_doc_number] => 10292958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Lipid-containing compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 13/332251
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19697
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13332251
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/332251 | Lipid-containing compositions and methods of use thereof | Dec 19, 2011 | Issued |
Array
(
[id] => 10114604
[patent_doc_number] => 09149468
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Multicomponent crystals made ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid'
[patent_app_type] => utility
[patent_app_number] => 13/992247
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4528
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992247
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992247 | Multicomponent crystals made ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid | Dec 19, 2011 | Issued |
Array
(
[id] => 9082081
[patent_doc_number] => 20130267611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'COSMETIC COMPOSITION COMPRISING A SUPRAMOLECULAR COMPOUND CAPABLE OF ESTABLISHING HYDROGEN BONDS, A SILICONE OIL AND A WAX'
[patent_app_type] => utility
[patent_app_number] => 13/993240
[patent_app_country] => US
[patent_app_date] => 2011-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26011
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993240
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993240 | COSMETIC COMPOSITION COMPRISING A SUPRAMOLECULAR COMPOUND CAPABLE OF ESTABLISHING HYDROGEN BONDS, A SILICONE OIL AND A WAX | Dec 11, 2011 | Abandoned |
Array
(
[id] => 8664499
[patent_doc_number] => 08377961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-19
[patent_title] => 'Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53'
[patent_app_type] => utility
[patent_app_number] => 13/307153
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15738
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13307153
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/307153 | Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 | Nov 29, 2011 | Issued |
Array
(
[id] => 9055240
[patent_doc_number] => 20130252953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'Targeting Human Thymidylate Kinase Induces DNA Repair Toxicity in Malignant Tumor Cells'
[patent_app_type] => utility
[patent_app_number] => 13/990398
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32634
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990398
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/990398 | Targeting human thymidylate kinase induces DNA repair toxicity in malignant tumor cells | Nov 28, 2011 | Issued |
Array
(
[id] => 8043585
[patent_doc_number] => 20120071532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 13/301979
[patent_app_country] => US
[patent_app_date] => 2011-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12835
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071532.pdf
[firstpage_image] =>[orig_patent_app_number] => 13301979
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/301979 | Solid forms of bendamustine hydrochloride | Nov 21, 2011 | Issued |
Array
(
[id] => 8995035
[patent_doc_number] => 08518919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Compositions comprising azelastine and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/294069
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43331
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13294069
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/294069 | Compositions comprising azelastine and methods of use thereof | Nov 9, 2011 | Issued |
Array
(
[id] => 9875412
[patent_doc_number] => 08962680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Methods and compositions for treating HIV-associated diarrhea'
[patent_app_type] => utility
[patent_app_number] => 13/285397
[patent_app_country] => US
[patent_app_date] => 2011-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19459
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13285397
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/285397 | Methods and compositions for treating HIV-associated diarrhea | Oct 30, 2011 | Issued |
Array
(
[id] => 13090987
[patent_doc_number] => 10064817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Compositions comprising azelastine and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 13/284836
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 45376
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13284836
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/284836 | Compositions comprising azelastine and methods of use thereof | Oct 27, 2011 | Issued |
Array
(
[id] => 8211648
[patent_doc_number] => 20120129943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'METHOD OF INCREASING OR MAINTAINING THE REPRODUCTIVE PERFORMANCE OF SOWS'
[patent_app_type] => utility
[patent_app_number] => 13/282682
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8330
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129943.pdf
[firstpage_image] =>[orig_patent_app_number] => 13282682
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282682 | Method of increasing or maintaining the reproductive performance of sows | Oct 26, 2011 | Issued |
Array
(
[id] => 9238750
[patent_doc_number] => 08603539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Compositions for drug delivery'
[patent_app_type] => utility
[patent_app_number] => 13/274650
[patent_app_country] => US
[patent_app_date] => 2011-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9032
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13274650
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/274650 | Compositions for drug delivery | Oct 16, 2011 | Issued |
Array
(
[id] => 8398474
[patent_doc_number] => 08268856
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter'
[patent_app_type] => utility
[patent_app_number] => 13/253958
[patent_app_country] => US
[patent_app_date] => 2011-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 31
[patent_no_of_words] => 8643
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13253958
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/253958 | Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter | Oct 4, 2011 | Issued |
Array
(
[id] => 8241032
[patent_doc_number] => 20120149770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'Antimicrobial Preservation of Propofol Emulsions'
[patent_app_type] => utility
[patent_app_number] => 13/252667
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3246
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252667
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252667 | Antimicrobial preservation of propofol emulsions | Oct 3, 2011 | Issued |
Array
(
[id] => 8173850
[patent_doc_number] => 20120108623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN'
[patent_app_type] => utility
[patent_app_number] => 13/252982
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12315
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108623.pdf
[firstpage_image] =>[orig_patent_app_number] => 13252982
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252982 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | Oct 3, 2011 | Abandoned |
Array
(
[id] => 8094051
[patent_doc_number] => 20120082628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'Oral Care Compositions With Improved Flavor'
[patent_app_type] => utility
[patent_app_number] => 13/248308
[patent_app_country] => US
[patent_app_date] => 2011-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16865
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20120082628.pdf
[firstpage_image] =>[orig_patent_app_number] => 13248308
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/248308 | Oral care compositions with improved flavor | Sep 28, 2011 | Issued |
Array
(
[id] => 8940571
[patent_doc_number] => 20130190368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'NOVEL POLYMORPHS OF FEBUXOSTAT'
[patent_app_type] => utility
[patent_app_number] => 13/825689
[patent_app_country] => US
[patent_app_date] => 2011-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2835
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825689
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/825689 | NOVEL POLYMORPHS OF FEBUXOSTAT | Aug 22, 2011 | Abandoned |
Array
(
[id] => 13104851
[patent_doc_number] => 10071054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Econazole composition and methods of treatment therewith
[patent_app_type] => utility
[patent_app_number] => 13/198998
[patent_app_country] => US
[patent_app_date] => 2011-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11146
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13198998
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/198998 | Econazole composition and methods of treatment therewith | Aug 4, 2011 | Issued |
Array
(
[id] => 7757110
[patent_doc_number] => 20120029037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'ANIMAL ECTOPARASITE-CONTROLLING AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/193749
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20791
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20120029037.pdf
[firstpage_image] =>[orig_patent_app_number] => 13193749
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/193749 | ANIMAL ECTOPARASITE-CONTROLLING AGENT | Jul 28, 2011 | Abandoned |
Array
(
[id] => 10613332
[patent_doc_number] => 09332758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Compositions containing 1,2-benzisothiazolin-3-one'
[patent_app_type] => utility
[patent_app_number] => 13/187599
[patent_app_country] => US
[patent_app_date] => 2011-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4107
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187599
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/187599 | Compositions containing 1,2-benzisothiazolin-3-one | Jul 20, 2011 | Issued |
Array
(
[id] => 8940607
[patent_doc_number] => 20130190404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'CRYSTALS OF CARBOPROST TROMETHAMINE AND THE PREPARATION METHOD AS WELL AS THE USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/811200
[patent_app_country] => US
[patent_app_date] => 2011-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4064
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811200
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/811200 | CRYSTALS OF CARBOPROST TROMETHAMINE AND THE PREPARATION METHOD AS WELL AS THE USES THEREOF | Jul 19, 2011 | Abandoned |